MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2

Published:2023-10 Issue:7 Volume:23 Page:e480-e490.e3
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Mansoori Behnaz,Kiani Shiva,Mezajin Alireza Ashrafi,Zandi Pouyan,Banaie Homadokht,Rostamzadeh Davoud,Cho William C.,Duijf Pascal H.G.,Mansoori Behzad^ORCID,Baradaran Behzad

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer;Fedele;Crit Rev Oncol Hematol,2015

3. Mechanisms for estrogen receptor expression in human cancer 11 medical and health sciences 1112 oncology and carcinogenesis 06 biological sciences 0604 genetics;Hua;Exp Hematol Oncol,2018

4. MicroRNA-based therapy and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment;Kaboli;Pharmacol Res,2015

5. miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process;Pan;Onco Targets Ther,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HMGA2 promotes cancer metastasis by regulating epithelial–mesenchymal transition;Frontiers in Oncology;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP